DNS - Adalimumab - HYRIMOZ
Economic Operator with Whom the Contract Has Been Concluded
| Show detail | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1483/2021-SML | 26. 10. 2021 | PROMEDICA PRAHA GROUP, a.s. | 3 623 678,08 | 3 294 252,80 | 3 623 678,08 | 3 294 252,80 | CZK |
Published Documents
List of Participants
| Show detail | ||||||
|---|---|---|---|---|---|---|
| PROMEDICA PRAHA GROUP, a.s. | Praha |
Price Actually Paid in Each Year of Performance
| 1483/2021-SML | 2023 | 1 662 500,00 | 1 511 363,60 |
| 1483/2021-SML | 2022 | 1 638 432,80 | 1 489 483,54 |
| 1483/2021-SML | 2021 | 322 734,00 | 293 394,39 |